|
Originally published In Press as doi:10.1074/jbc.M209982200 on November 4, 2002
J. Biol. Chem., Vol. 278, Issue 3, 1991-1997, January 17, 2003
Endosome-to-Golgi Transport Is Regulated by
Protein Kinase A Type II *
Kim Are
Birkeli ,
Alicia
Llorente ,
Maria L.
Torgersen ,
Guy
Keryer§,
Kjetil
Taskén¶, and
Kirsten
Sandvig
From the Institute for Cancer Research, The Norwegian
Radium Hospital, Montebello, 0310 Oslo, Norway, § Institut
Curie, Biologie du Cycle Cellulaire et de la Motilité, 75248 Paris Cedex 05, France, and the ¶ Institute of Medical
Biochemistry, University of Oslo, 0317 Oslo, Norway
Studies of RII -deficient B lymphoid cells and
stable transfectants expressing the type II regulatory subunit
(RII ) of cAMP-dependent protein kinase (PKA), which is
targeted to the Golgi-centrosomal area, reveal that the presence of a
Golgi-associated pool of PKA type II mediates a change in
intracellular transport of the plant toxin ricin. The transport of
ricin from endosomes to the Golgi apparatus, measured as sulfation of a
modified ricin (ricin sulf-1), increased in RII -expressing cells
when PKA was activated. However, not only endosome-to-Golgi transport,
but also retrograde ricin transport to the endoplasmic reticulum (ER),
measured as sulfation and N-glycosylation of another
modified ricin (ricin sulf-2), seemed to be increased in cells
expressing RII in the presence of a cAMP analog,
8-(4-chlorophenylthio)-cAMP. Thus, PKA type II seems to be
involved in both endosome-to-Golgi and Golgi-to-ER transport. Because
ricin, after being retrogradely transported to the ER, is translocated
to the cytosol, where it inhibits protein synthesis, we also
investigated the influence of RII expression on ricin toxicity. In
agreement with the other data obtained, 8-(4-chlorophenylthio)-cAMP and
RII were found to sensitize cells to ricin, indicating an increased
transport of ricin to the cytosol. In conclusion, our results
demonstrate that transport of ricin from endosomes to the Golgi
apparatus and further to the ER is regulated by PKA type II isozyme.
*
This work was supported by the Norwegian Research Council,
The Norwegian Cancer Society, Novo Nordic Research Foundation, Anders
Jahre's Foundation, and Jeanette & Søren Bothners legacy.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
47-22-93-42-94; Fax: 47-22-50-86-92; E-mail:
ksandvig@radium.uio.no.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Farquhar, H. J. Harris, M. Diskar, S. Jones, C. J. Mee, S. U. Nielsen, C. L. Brimacombe, S. Molina, G. L. Toms, P. Maurel, et al.
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity
J. Virol.,
September 1, 2008;
82(17):
8797 - 8811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ishizaki, H.-W. Shin, S. M. M. Iguchi-Ariga, H. Ariga, and K. Nakayama
AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors.
Genes Cells,
August 1, 2006;
11(8):
949 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-W. Shin and K. Nakayama
Guanine Nucleotide-Exchange Factors for Arf GTPases: Their Diverse Functions in Membrane Traffic
J. Biochem.,
December 1, 2004;
136(6):
761 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Larocca, R. A. Shanks, L. Tian, D. L. Nelson, D. M. Stewart, and J. R. Goldenring
AKAP350 Interaction with cdc42 Interacting Protein 4 at the Golgi Apparatus
Mol. Biol. Cell,
June 1, 2004;
15(6):
2771 - 2781.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|